Virtu Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Virtu Financial's NBIX Position: Q3 2026 in Review
Virtu Financial sold out of Neurocrine Biosciences (NBIX) in Q3 2026, closing a stake of 1,861 shares — an estimated $314K sold.
Virtu Financial first reported a position in NBIX in Q1 2018 and held it in 17 quarters. The position peaked at $2.18M in Q4 2025. 772 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Virtu Financial reported no remaining Neurocrine Biosciences position as of Q3 2026 after selling out during the quarter.
- Virtu Financial sold 1,861 Neurocrine Biosciences shares in Q3 2026, an estimated $314K.
- Virtu Financial first reported a position in Neurocrine Biosciences in Q1 2018 and held it in 17 quarters.
- Virtu Financial's Neurocrine Biosciences position peaked at $2.18M in Q4 2025.
- 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.